|
1
|
Zhang L, Ge W, Hu K, et al: Endostar
down-regulates HIF-1 and VEGF expression and enhances the
radioresponse to human lung adenocarcinoma cancer cells. Mol Biol
Rep. 39:89–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ge W, Zheng Y, Zhang L, et al: Endostar
enhances the radioresponse on lewis lung carcinoma by regulating
HIF-1α. Biomed Eng Informatics. 3:1486–1490. 2011.
|
|
3
|
Huang G and Chen L: Recombinant human
endostatin improves anti-tumor efficacy of paclitaxel by
normalizing tumor vasculature in Lewis lung carcinoma. J Cancer Res
Clin Oncol. 136:1201–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cosgrove D and Lassau N: Imaging of
perfusion using ultrasound. Eur J Nucl Med Mol Imaging. 37(Suppl
1): S65–S85. 2010. View Article : Google Scholar
|
|
5
|
Feingold S, Gessner R, Guracar IM and
Dayton PA: Quantitative volumetric perfusion mapping of the
microvasculature using contrast ultrasound. Invest Radiol.
45:669–674. 2010.PubMed/NCBI
|
|
6
|
Quaia E: Assessment of tissue perfusion by
contrast-enhanced ultrasound. Eur Radiol. 21:604–615. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ochoa LN, Henao E, Lumsden A and Bush RL:
Contrast-enhanced ultrasound. Noninvasive Vascular Diagnosis: A
Practical Guide to Therapy. AbuRahma AF and Bergan JJ: 2nd edition.
Springer; New York, NY: pp. 529–545. 2007, View Article : Google Scholar
|
|
8
|
Qin S, Caskey CF and Ferrara KW:
Ultrasound contrast microbubbles in imaging and therapy: physical
principles and engineering. Phys Med Biol. 54:R27–R57. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gauthier TP, Averkiou MA and Leen EL:
Perfusion quantification using dynamic contrast-enhanced
ultrasound: the impact of dynamic range and gain on time-intensity
curves. Ultrasonics. 51:102–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pompili M, Riccardi L, Covino M, et al:
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy
assessment of ablation treatments for hepatocellular carcinoma.
Liver Int. 25:954–961. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sirsi SR, Flexman ML, Vlachos F, et al:
Contrast ultrasound imaging for identification of early responder
tumor models to anti-angiogenic therapy. Ultrasound Med Biol.
38:1019–1029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du H, Ge W, Li C, Zhao Z, Xu X and Yang F:
Effects of rh-endostar in combination with radiotherapy on rats
with lung cancer. Zhongguo Fei Ai Za Zhi. 13:386–390. 2010.(In
Chinese).
|
|
13
|
Huang R, Zhan Q, Zhou X, Chu Z, Jiang J
and Liang X: Continuous administration of recombinant human
endostatin (Endostar): A pre-clinical safety study. Exp Ther Med.
3:1018–1022. 2012.PubMed/NCBI
|
|
14
|
Goetti R, Reiner CS, Knuth A, et al:
Quantitative perfusion analysis of malignant liver tumors: dynamic
computed tomography and contrast-enhanced ultrasound. Invest
Radiol. 47:18–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang TB, Wei XQ, Lin WH, Shi HP and Dong
WG: The inhibition of Endostar on the angiogenesis and growth of
gastrointestinal stromal tumor xenograft. Clin Exp Med. 12:89–95.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan ES, Patel AR, Larchian WA and Heston
WD: In vivo targeted contrast enhanced micro-ultrasound to measure
intratumor perfusion and vascular endothelial growth factor
receptor 2 expression in a mouse orthotopic bladder cancer model. J
Urol. 185:2359–2365. 2011. View Article : Google Scholar
|
|
17
|
Zhou N, Hu G, Mei Q, Qiu H, Long G, Chen C
and Guoqing H: Inhibitory effect of endostar in combination with
radiotherapy in a mouse model of human CNE2 nasopharyngeal
carcinoma. J Huazhong Univ Sci Technolog Med Sci. 31:62–66. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ke QH, Zhou SQ, Huang M, Lei Y, Du W and
Yang JY: Early efficacy of Endostar combined with chemoradiotherapy
for advanced cervical cancers. Asian Pac J Cancer Prev. 13:923–926.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng F, Xu Z, Wang J, et al: Recombinant
human endostatin normalizes tumor vasculature and enhances
radiation response in xenografted human nasopharyngeal carcinoma
models. PLoS One. 7:e346462012. View Article : Google Scholar
|
|
20
|
Yuan Z, Quan J, Yunxiao Z, et al:
Diagnostic value of contrast-enhanced ultrasound parametric imaging
in breast tumors. J Breast Cancer. 16:208–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen QL, Meng MB, Yang B, et al: Endostar,
a recombined humanized endostatin, enhances the radioresponse for
human nasopharyngeal carcinoma and human lung adenocarcinoma
xenografts in mice. Cancer Sci. 100:1510–1519. 2009. View Article : Google Scholar : PubMed/NCBI
|
